Audentes Therapeutics to Participate in Upcoming Investor Conferences

Date : 11/26/2019 @ 9:01PM
Source : Business Wire
Stock : Audentes Therapeutics Inc (BOLD)
Quote : 59.97  0.0 (0.00%) @ 12:00AM
Audentes Therapeutics share price Chart

Audentes Therapeutics to Participate in Upcoming Investor Conferences

Audentes Therapeutics (NASDAQ:BOLD)
Historical Stock Chart

2 Months : From Nov 2019 to Jan 2020

Click Here for more Audentes Therapeutics Charts.

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, today announced that Natalie Holles, President and Chief Operating Officer, will participate in the following investor conferences in December:

31st Annual Piper Jaffray Healthcare Conference Fireside Chat: Tuesday, December 3, 2019, at 10:00am ET New York, New York

2nd Annual Evercore ISI HealthCONx Panel: “Gene Therapy Manufacturing Powerhouses,” Wednesday, December 4, 2019, at 8:45am ET Boston, Massachusetts

To access the live webcast of the Piper Jaffray fireside chat, please visit the Events & Presentations page within the Investors + Media section of the Audentes website. Following the conference, a replay of the live webcast will be available on the Audentes website for approximately 30 days. There is no webcast available for the Gene Therapy Manufacutring Powerhouses panel at the Evercore ISI HealthCONx conference.

About Audentes Therapeutics, Inc.

Audentes Therapeutics (Nasdaq: BOLD) is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients.

For more information regarding Audentes, please visit www.audentestx.com.

Investor Contact: Andrew Chang 415.818.1033 achang@audentestx.com

Media Contact: Sarah Spencer 415.957.2020 sspencer@audentestx.com

Latest BOLD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200119 02:37:32